Sandoz Recalls Ropinirole Extended-Release Tablets Due to Cross-Contamination
Sandoz is recalling specific lots of Ropinirole Extended-Release Tablets 2 mg due to potential cross-contamination with mycophenolate mofetil.
- Product
- Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92
- Category
- Drug
- Distribution
- Distributed nationwide